Find people, groups, projects, media, etc.
-
Go to homepage

Publications

Updated: 30, Jan 2026

2025

  • Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia: summary of recommendations
    2025 | journal-article
    DOI: 10.5694/mja2.70061
  • The IC3 trial: protocol for a multicentre individually randomised controlled trial to compare a cirrhosis detection and hepatocellular carcinoma surveillance pathway vs usual care in Australian general practice for 45–75 years old with risk factors for chronic liver disease
    2025 | journal-article
    DOI: 10.1186/s13063-025-09037-9
  • Treatment outcomes for people with hepatitis C referred to tertiary care in Victoria, 2021–22: a retrospective observational study
    2025 | journal-article
    DOI: 10.5694/mja2.70017
  • Inequities in COVID-19 antiviral dispensation in Victoria, Australia: A retrospective cohort study using linked data.
    2025 | journal-article
    PMID: 40908598; DOI: 10.31128/ajgp-06-24-7312
    URL: http://europepmc.org/abstract/med/40908598
  • Disease progression & treatment need in sub-genotype C4 hepatitis B infection: a retrospective cohort study in the Northern Territory, Australia
    2025 | journal-article
    DOI: 10.1186/s12879-025-11213-w
  • Pathogens don’t respect politicians: US federal disruption poses a new threat to global public health
    2025 | journal-article
    DOI: 10.1016/s2468-1253(25)00045-7
  • Protektem pikinini blong yu trial: protocol for a single arm field trial to assess the effectiveness of treating-all pregnant women with hepatitis B infection with tenofovir prophylaxis to prevent mother-to-child transmission in Vanuatu, 2024–2025
    2025 | journal-article
    DOI: 10.1186/s12889-024-20946-3 

2024

  • The cascade of care for hepatitis C in Victoria, Australia: a data linkage cohort study
    2024 | journal-article
    DOI: 10.1111/imj.16361

2023

  • Effectiveness of Community-Based Oral Antiviral Treatments Against Severe COVID-19 Outcomes in Victoria, Australia, 2022: An Observational Study
    2023 | other
    DOI: 10.2139/ssrn.4495142;
  • Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
    2023 | journal-article
    DOI: 10.1016/s2468-1253(23)00197-8
  • Access to oral COVID ‐19 antivirals in the community: are eligibility criteria and systems ensuring equity?
    2023 | journal-article
    DOI: 10.5694/mja2.51949
  • Progress towards triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis in Pacific Island Countries and Territories: a systematic review
    2023 | journal-article
    DOI: 10.1016/j.lanwpc.2023.100740
  • Excess mortality among people with communicable diseases over a 30-year period, Victoria, Australia: a whole of population cohort study
    2023 | journal-article
    DOI: 10.1016/j.lanwpc.2023.100815

2022

2021

2020

2019

2018

2017

2016

2015

Site by Sod